Gelsomino F, Tiseo M, Barbieri F, Riccardi F, et al. Correction to: Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL). Br J Cancer 2021 May 19. pii: 10.1038/s41416-021-01439.
PMID: 34012035